Abstract
Dyslipidemia and diabetes mellitus are among the leading risk factors for atherosclerosis. Statins act as first-line drugs in the correction of dyslipidemia. However, most statins can increase the risk of developing and worsen the course of type 2 diabetes. Pitavastatin is the only statin that can increase the level of adiponectin and thus have a beneficial effect on glucose metabolism. The author gives an example of the use of pitavastatin in a patient with insulin resistance and a high risk of developing type 2 diabetes mellitus.
Keywords: dyslipidemia, statin-induced diabetes, adiponectin, pitavastatin, insulin resistance.
Keywords: dyslipidemia, statin-induced diabetes, adiponectin, pitavastatin, insulin resistance.
For citation:Shtegman O.A. Clinical case of treating hypercholesterolemia associated with impaired fasting glycemia. Clinical review for general practice. 2025; 6 (1): 14–16 (In Russ.). DOI: 10.47407/kr2024.6.1.00544
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
